EFFICACY OF KINVA UPANAHA (POULTICE) ON INFLAMMATORY BIOMARKERS IN KNEE OSTEOARTHRITIS – A PILOT STUDY Authors: Gramapurohit PL* And Sutagatti KB
ABSTRACT
Introduction: Osteoarthritis is a low grade inflammatory and degenerative joint disease
involving varies of molecular interactions between the tissues that form the joint. Janu Sandhigata
Vata can be understood in parlance with knee osteoarthritis (OA) which has a great impact on the
quality of life. This study is aimed to evaluate the effect of kinva upanaha on inflammatory
biomarkers in janu sandhigata vata. Objectives: To evaluate the efficacy of Kinva Upanaha on
inflammatory biomarkers (TNF- ? IL- 6) in Knee osteoarthritis w.s.r to Janu Sandhigata Vata.
Methods: Basic Phytochemical, Microbial testAmrutarishta Kinva were done and kinva upanaha
was done for 20 diagnosed patients of janu sandhigata vata for 7 days for 5 hours duration. Janu
Sandhi shola by Visual analogue scale, Knee Range of Movements were assessed on 7th day and
14th day from the day of enrollment, whereas inflammatory biomarkers (TNF- ? IL- 6) were
assessed on the 1st and 7th day from the day of enrollment. The paired “t” test and the Wilcoxon
match-paired test were applied to evaluate the results. Results: Kinva Upanaha therapy showed
reduction in serum levels of inflammatory biomarkers (TNF-? and IL- 6) and improvement in Knee
pain and Knee Range of movements too. Conclusion: Kinva upanaha yielded positive subjectiveand inflammatory biomarker outcomes in knee osteoarthritis. Kinva is residueand is discarded by
most of the pharmacies but this can become an economical and potent upanaha drug in knee
osteoarthritis.
Keywords: Inflammatory biomarkers, Knee osteoarthritis, Kinva Upanaha Sweda Publication date: 01/01/2026 https://ijbpas.com/pdf/2026/January/MS_IJBPAS_2026_9765.pdfDownload PDFhttps://doi.org/10.31032/IJBPAS/2026/15.1.9765